↓ Skip to main content

Transdermal fentanyl for cancer pain

Overview of attention for article published in Cochrane database of systematic reviews, October 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (94th percentile)
  • Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

policy
1 policy source
twitter
37 tweeters

Citations

dimensions_citation
47 Dimensions

Readers on

mendeley
2 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Transdermal fentanyl for cancer pain
Published in
Cochrane database of systematic reviews, October 2013
DOI 10.1002/14651858.cd010270.pub2
Pubmed ID
Authors

Gina Hadley, Sheena Derry, R Andrew Moore, Philip J Wiffen

Abstract

Opioid drugs have been used for many years to relieve pain. Transdermal fentanyl offers one option for delivering and maintaining pain relief in patients with moderate or severe cancer pain.

Twitter Demographics

The data shown below were collected from the profiles of 37 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 2 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
France 1 50%
Unknown 1 50%

Demographic breakdown

Readers by professional status Count As %
Student > Master 26 1300%
Student > Bachelor 21 1050%
Researcher 20 1000%
Other 16 800%
Unspecified 15 750%
Other 41 2050%
Readers by discipline Count As %
Medicine and Dentistry 75 3750%
Unspecified 21 1050%
Nursing and Health Professions 10 500%
Psychology 9 450%
Pharmacology, Toxicology and Pharmaceutical Science 7 350%
Other 17 850%

Attention Score in Context

This research output has an Altmetric Attention Score of 24. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 October 2019.
All research outputs
#686,452
of 13,622,686 outputs
Outputs from Cochrane database of systematic reviews
#2,157
of 10,684 outputs
Outputs of similar age
#9,827
of 166,035 outputs
Outputs of similar age from Cochrane database of systematic reviews
#24
of 110 outputs
Altmetric has tracked 13,622,686 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 10,684 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.1. This one has done well, scoring higher than 79% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 166,035 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 110 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 78% of its contemporaries.